img

Global Artificial Heart and Ventricular Assist Devices Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 123 | Industry : Medical Devices & Consumables

Publisher : q | Format : PDF

Global Artificial Heart and Ventricular Assist Devices Market Research Report 2024

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
Artificial Heart
Ventricular Assist Devices


Segment by Application


Coronary Heart Disease
Cerebrovascular Disease
Peripheral Arterial Disease
Rheumatic Heart Disease
Congenital Heart Disease
Deep Vein Thrombosis
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE




By Company


SynCardia Systems
Medtronic PLC
Abbott Laboratories
BiVACOR
Berlin Heart
ABIOMED
LivaNova PLC
CARMAT
Jarvik Heart Inc
Chongqing Yongrenxin Medical
Thoratec
Cleveland Heart
CryoLife

Table of Content

1 Artificial Heart and Ventricular Assist Devices Market Overview
1.1 Product Overview and Scope of Artificial Heart and Ventricular Assist Devices
1.2 Artificial Heart and Ventricular Assist Devices Segment by Type
1.2.1 Global Artificial Heart and Ventricular Assist Devices Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Artificial Heart
1.2.3 Ventricular Assist Devices
1.3 Artificial Heart and Ventricular Assist Devices Segment by Application
1.3.1 Artificial Heart and Ventricular Assist Devices Sales Comparison by Application: (2021-2027)
1.3.2 Coronary Heart Disease
1.3.3 Cerebrovascular Disease
1.3.4 Peripheral Arterial Disease
1.3.5 Rheumatic Heart Disease
1.3.6 Congenital Heart Disease
1.3.7 Deep Vein Thrombosis
1.3.8 Other
1.4 Global Artificial Heart and Ventricular Assist Devices Market Size Estimates and Forecasts
1.4.1 Global Artificial Heart and Ventricular Assist Devices Revenue 2016-2027
1.4.2 Global Artificial Heart and Ventricular Assist Devices Sales 2016-2027
1.4.3 Artificial Heart and Ventricular Assist Devices Market Size by Region: 2016 Versus 2021 Versus 2027

2 Artificial Heart and Ventricular Assist Devices Market Competition by Manufacturers
2.1 Global Artificial Heart and Ventricular Assist Devices Sales Market Share by Manufacturers (2016-2021)
2.2 Global Artificial Heart and Ventricular Assist Devices Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Artificial Heart and Ventricular Assist Devices Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Artificial Heart and Ventricular Assist Devices Manufacturing Sites, Area Served, Product Type
2.5 Artificial Heart and Ventricular Assist Devices Market Competitive Situation and Trends
2.5.1 Artificial Heart and Ventricular Assist Devices Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Artificial Heart and Ventricular Assist Devices Players Market Share by Revenue
2.5.3 Global Artificial Heart and Ventricular Assist Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Artificial Heart and Ventricular Assist Devices Retrospective Market Scenario by Region
3.1 Global Artificial Heart and Ventricular Assist Devices Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Artificial Heart and Ventricular Assist Devices Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Artificial Heart and Ventricular Assist Devices Market Facts & Figures by Country
3.3.1 North America Artificial Heart and Ventricular Assist Devices Sales by Country
3.3.2 North America Artificial Heart and Ventricular Assist Devices Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Artificial Heart and Ventricular Assist Devices Market Facts & Figures by Country
3.4.1 Europe Artificial Heart and Ventricular Assist Devices Sales by Country
3.4.2 Europe Artificial Heart and Ventricular Assist Devices Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Artificial Heart and Ventricular Assist Devices Market Facts & Figures by Region
3.5.1 Asia Pacific Artificial Heart and Ventricular Assist Devices Sales by Region
3.5.2 Asia Pacific Artificial Heart and Ventricular Assist Devices Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Artificial Heart and Ventricular Assist Devices Market Facts & Figures by Country
3.6.1 Latin America Artificial Heart and Ventricular Assist Devices Sales by Country
3.6.2 Latin America Artificial Heart and Ventricular Assist Devices Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Artificial Heart and Ventricular Assist Devices Market Facts & Figures by Country
3.7.1 Middle East and Africa Artificial Heart and Ventricular Assist Devices Sales by Country
3.7.2 Middle East and Africa Artificial Heart and Ventricular Assist Devices Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Artificial Heart and Ventricular Assist Devices Historic Market Analysis by Type
4.1 Global Artificial Heart and Ventricular Assist Devices Sales Market Share by Type (2016-2021)
4.2 Global Artificial Heart and Ventricular Assist Devices Revenue Market Share by Type (2016-2021)
4.3 Global Artificial Heart and Ventricular Assist Devices Price by Type (2016-2021)

5 Global Artificial Heart and Ventricular Assist Devices Historic Market Analysis by Application
5.1 Global Artificial Heart and Ventricular Assist Devices Sales Market Share by Application (2016-2021)
5.2 Global Artificial Heart and Ventricular Assist Devices Revenue Market Share by Application (2016-2021)
5.3 Global Artificial Heart and Ventricular Assist Devices Price by Application (2016-2021)

6 Key Companies Profiled
6.1 SynCardia Systems
6.1.1 SynCardia Systems Corporation Information
6.1.2 SynCardia Systems Description and Business Overview
6.1.3 SynCardia Systems Artificial Heart and Ventricular Assist Devices Sales, Revenue and Gross Margin (2016-2021)
6.1.4 SynCardia Systems Product Portfolio
6.1.5 SynCardia Systems Recent Developments/Updates
6.2 Medtronic PLC
6.2.1 Medtronic PLC Corporation Information
6.2.2 Medtronic PLC Description and Business Overview
6.2.3 Medtronic PLC Artificial Heart and Ventricular Assist Devices Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Medtronic PLC Product Portfolio
6.2.5 Medtronic PLC Recent Developments/Updates
6.3 Abbott Laboratories
6.3.1 Abbott Laboratories Corporation Information
6.3.2 Abbott Laboratories Description and Business Overview
6.3.3 Abbott Laboratories Artificial Heart and Ventricular Assist Devices Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Abbott Laboratories Product Portfolio
6.3.5 Abbott Laboratories Recent Developments/Updates
6.4 BiVACOR
6.4.1 BiVACOR Corporation Information
6.4.2 BiVACOR Description and Business Overview
6.4.3 BiVACOR Artificial Heart and Ventricular Assist Devices Sales, Revenue and Gross Margin (2016-2021)
6.4.4 BiVACOR Product Portfolio
6.4.5 BiVACOR Recent Developments/Updates
6.5 Berlin Heart
6.5.1 Berlin Heart Corporation Information
6.5.2 Berlin Heart Description and Business Overview
6.5.3 Berlin Heart Artificial Heart and Ventricular Assist Devices Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Berlin Heart Product Portfolio
6.5.5 Berlin Heart Recent Developments/Updates
6.6 ABIOMED
6.6.1 ABIOMED Corporation Information
6.6.2 ABIOMED Description and Business Overview
6.6.3 ABIOMED Artificial Heart and Ventricular Assist Devices Sales, Revenue and Gross Margin (2016-2021)
6.6.4 ABIOMED Product Portfolio
6.6.5 ABIOMED Recent Developments/Updates
6.7 LivaNova PLC
6.6.1 LivaNova PLC Corporation Information
6.6.2 LivaNova PLC Description and Business Overview
6.6.3 LivaNova PLC Artificial Heart and Ventricular Assist Devices Sales, Revenue and Gross Margin (2016-2021)
6.4.4 LivaNova PLC Product Portfolio
6.7.5 LivaNova PLC Recent Developments/Updates
6.8 CARMAT
6.8.1 CARMAT Corporation Information
6.8.2 CARMAT Description and Business Overview
6.8.3 CARMAT Artificial Heart and Ventricular Assist Devices Sales, Revenue and Gross Margin (2016-2021)
6.8.4 CARMAT Product Portfolio
6.8.5 CARMAT Recent Developments/Updates
6.9 Jarvik Heart Inc
6.9.1 Jarvik Heart Inc Corporation Information
6.9.2 Jarvik Heart Inc Description and Business Overview
6.9.3 Jarvik Heart Inc Artificial Heart and Ventricular Assist Devices Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Jarvik Heart Inc Product Portfolio
6.9.5 Jarvik Heart Inc Recent Developments/Updates
6.10 Chongqing Yongrenxin Medical
6.10.1 Chongqing Yongrenxin Medical Corporation Information
6.10.2 Chongqing Yongrenxin Medical Description and Business Overview
6.10.3 Chongqing Yongrenxin Medical Artificial Heart and Ventricular Assist Devices Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Chongqing Yongrenxin Medical Product Portfolio
6.10.5 Chongqing Yongrenxin Medical Recent Developments/Updates
6.11 Thoratec
6.11.1 Thoratec Corporation Information
6.11.2 Thoratec Artificial Heart and Ventricular Assist Devices Description and Business Overview
6.11.3 Thoratec Artificial Heart and Ventricular Assist Devices Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Thoratec Product Portfolio
6.11.5 Thoratec Recent Developments/Updates
6.12 Cleveland Heart
6.12.1 Cleveland Heart Corporation Information
6.12.2 Cleveland Heart Artificial Heart and Ventricular Assist Devices Description and Business Overview
6.12.3 Cleveland Heart Artificial Heart and Ventricular Assist Devices Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Cleveland Heart Product Portfolio
6.12.5 Cleveland Heart Recent Developments/Updates
6.13 CryoLife
6.13.1 CryoLife Corporation Information
6.13.2 CryoLife Artificial Heart and Ventricular Assist Devices Description and Business Overview
6.13.3 CryoLife Artificial Heart and Ventricular Assist Devices Sales, Revenue and Gross Margin (2016-2021)
6.13.4 CryoLife Product Portfolio
6.13.5 CryoLife Recent Developments/Updates

7 Artificial Heart and Ventricular Assist Devices Manufacturing Cost Analysis
7.1 Artificial Heart and Ventricular Assist Devices Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Artificial Heart and Ventricular Assist Devices
7.4 Artificial Heart and Ventricular Assist Devices Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Artificial Heart and Ventricular Assist Devices Distributors List
8.3 Artificial Heart and Ventricular Assist Devices Customers

9 Artificial Heart and Ventricular Assist Devices Market Dynamics
9.1 Artificial Heart and Ventricular Assist Devices Industry Trends
9.2 Artificial Heart and Ventricular Assist Devices Growth Drivers
9.3 Artificial Heart and Ventricular Assist Devices Market Challenges
9.4 Artificial Heart and Ventricular Assist Devices Market Restraints

10 Global Market Forecast
10.1 Artificial Heart and Ventricular Assist Devices Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Artificial Heart and Ventricular Assist Devices by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Artificial Heart and Ventricular Assist Devices by Type (2022-2027)
10.2 Artificial Heart and Ventricular Assist Devices Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Artificial Heart and Ventricular Assist Devices by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Artificial Heart and Ventricular Assist Devices by Application (2022-2027)
10.3 Artificial Heart and Ventricular Assist Devices Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Artificial Heart and Ventricular Assist Devices by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Artificial Heart and Ventricular Assist Devices by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Artificial Heart and Ventricular Assist Devices Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Artificial Heart and Ventricular Assist Devices Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Artificial Heart and Ventricular Assist Devices Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Artificial Heart and Ventricular Assist Devices Covered in This Study
Table 5. Global Artificial Heart and Ventricular Assist Devices Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Artificial Heart and Ventricular Assist Devices Sales Share by Manufacturers (2016-2021)
Table 7. Global Artificial Heart and Ventricular Assist Devices Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Artificial Heart and Ventricular Assist Devices Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Artificial Heart and Ventricular Assist Devices Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Artificial Heart and Ventricular Assist Devices Manufacturing Sites and Area Served
Table 11. Manufacturers Artificial Heart and Ventricular Assist Devices Product Type
Table 12. Global Artificial Heart and Ventricular Assist Devices Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Artificial Heart and Ventricular Assist Devices by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Artificial Heart and Ventricular Assist Devices as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Artificial Heart and Ventricular Assist Devices Sales by Region (2016-2021) & (K Units)
Table 16. Global Artificial Heart and Ventricular Assist Devices Sales Market Share by Region (2016-2021)
Table 17. Global Artificial Heart and Ventricular Assist Devices Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Artificial Heart and Ventricular Assist Devices Sales by Country (2016-2021) & (K Units)
Table 19. North America Artificial Heart and Ventricular Assist Devices Sales Market Share by Country (2016-2021)
Table 20. North America Artificial Heart and Ventricular Assist Devices Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Artificial Heart and Ventricular Assist Devices Revenue Market Share by Country (2016-2021)
Table 22. Europe Artificial Heart and Ventricular Assist Devices Sales by Country (2016-2021) & (K Units)
Table 23. Europe Artificial Heart and Ventricular Assist Devices Sales Market Share by Country (2016-2021)
Table 24. Europe Artificial Heart and Ventricular Assist Devices Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Artificial Heart and Ventricular Assist Devices Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Artificial Heart and Ventricular Assist Devices Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Artificial Heart and Ventricular Assist Devices Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Artificial Heart and Ventricular Assist Devices Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Artificial Heart and Ventricular Assist Devices Revenue Market Share by Region (2016-2021)
Table 30. Latin America Artificial Heart and Ventricular Assist Devices Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Artificial Heart and Ventricular Assist Devices Sales Market Share by Country (2016-2021)
Table 32. Latin America Artificial Heart and Ventricular Assist Devices Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Artificial Heart and Ventricular Assist Devices Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Artificial Heart and Ventricular Assist Devices Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Artificial Heart and Ventricular Assist Devices Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Artificial Heart and Ventricular Assist Devices Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Artificial Heart and Ventricular Assist Devices Revenue Market Share by Country (2016-2021)
Table 38. Global Artificial Heart and Ventricular Assist Devices Sales (K Units) by Type (2016-2021)
Table 39. Global Artificial Heart and Ventricular Assist Devices Sales Market Share by Type (2016-2021)
Table 40. Global Artificial Heart and Ventricular Assist Devices Revenue (Million US$) by Type (2016-2021)
Table 41. Global Artificial Heart and Ventricular Assist Devices Revenue Share by Type (2016-2021)
Table 42. Global Artificial Heart and Ventricular Assist Devices Price (US$/Unit) by Type (2016-2021)
Table 43. Global Artificial Heart and Ventricular Assist Devices Sales (K Units) by Application (2016-2021)
Table 44. Global Artificial Heart and Ventricular Assist Devices Sales Market Share by Application (2016-2021)
Table 45. Global Artificial Heart and Ventricular Assist Devices Revenue (Million US$) by Application (2016-2021)
Table 46. Global Artificial Heart and Ventricular Assist Devices Revenue Share by Application (2016-2021)
Table 47. Global Artificial Heart and Ventricular Assist Devices Price (US$/Unit) by Application (2016-2021)
Table 48. SynCardia Systems Corporation Information
Table 49. SynCardia Systems Description and Business Overview
Table 50. SynCardia Systems Artificial Heart and Ventricular Assist Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. SynCardia Systems Artificial Heart and Ventricular Assist Devices Product
Table 52. SynCardia Systems Recent Developments/Updates
Table 53. Medtronic PLC Corporation Information
Table 54. Medtronic PLC Description and Business Overview
Table 55. Medtronic PLC Artificial Heart and Ventricular Assist Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. Medtronic PLC Artificial Heart and Ventricular Assist Devices Product
Table 57. Medtronic PLC Recent Developments/Updates
Table 58. Abbott Laboratories Corporation Information
Table 59. Abbott Laboratories Description and Business Overview
Table 60. Abbott Laboratories Artificial Heart and Ventricular Assist Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. Abbott Laboratories Artificial Heart and Ventricular Assist Devices Product
Table 62. Abbott Laboratories Recent Developments/Updates
Table 63. BiVACOR Corporation Information
Table 64. BiVACOR Description and Business Overview
Table 65. BiVACOR Artificial Heart and Ventricular Assist Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. BiVACOR Artificial Heart and Ventricular Assist Devices Product
Table 67. BiVACOR Recent Developments/Updates
Table 68. Berlin Heart Corporation Information
Table 69. Berlin Heart Description and Business Overview
Table 70. Berlin Heart Artificial Heart and Ventricular Assist Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. Berlin Heart Artificial Heart and Ventricular Assist Devices Product
Table 72. Berlin Heart Recent Developments/Updates
Table 73. ABIOMED Corporation Information
Table 74. ABIOMED Description and Business Overview
Table 75. ABIOMED Artificial Heart and Ventricular Assist Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 76. ABIOMED Artificial Heart and Ventricular Assist Devices Product
Table 77. ABIOMED Recent Developments/Updates
Table 78. LivaNova PLC Corporation Information
Table 79. LivaNova PLC Description and Business Overview
Table 80. LivaNova PLC Artificial Heart and Ventricular Assist Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 81. LivaNova PLC Artificial Heart and Ventricular Assist Devices Product
Table 82. LivaNova PLC Recent Developments/Updates
Table 83. CARMAT Corporation Information
Table 84. CARMAT Description and Business Overview
Table 85. CARMAT Artificial Heart and Ventricular Assist Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 86. CARMAT Artificial Heart and Ventricular Assist Devices Product
Table 87. CARMAT Recent Developments/Updates
Table 88. Jarvik Heart Inc Corporation Information
Table 89. Jarvik Heart Inc Description and Business Overview
Table 90. Jarvik Heart Inc Artificial Heart and Ventricular Assist Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 91. Jarvik Heart Inc Artificial Heart and Ventricular Assist Devices Product
Table 92. Jarvik Heart Inc Recent Developments/Updates
Table 93. Chongqing Yongrenxin Medical Corporation Information
Table 94. Chongqing Yongrenxin Medical Description and Business Overview
Table 95. Chongqing Yongrenxin Medical Artificial Heart and Ventricular Assist Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 96. Chongqing Yongrenxin Medical Artificial Heart and Ventricular Assist Devices Product
Table 97. Chongqing Yongrenxin Medical Recent Developments/Updates
Table 98. Thoratec Corporation Information
Table 99. Thoratec Description and Business Overview
Table 100. Thoratec Artificial Heart and Ventricular Assist Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 101. Thoratec Artificial Heart and Ventricular Assist Devices Product
Table 102. Thoratec Recent Developments/Updates
Table 103. Cleveland Heart Corporation Information
Table 104. Cleveland Heart Description and Business Overview
Table 105. Cleveland Heart Artificial Heart and Ventricular Assist Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 106. Cleveland Heart Artificial Heart and Ventricular Assist Devices Product
Table 107. Cleveland Heart Recent Developments/Updates
Table 108. CryoLife Corporation Information
Table 109. CryoLife Description and Business Overview
Table 110. CryoLife Artificial Heart and Ventricular Assist Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 111. CryoLife Artificial Heart and Ventricular Assist Devices Product
Table 112. CryoLife Recent Developments/Updates
Table 113. Production Base and Market Concentration Rate of Raw Material
Table 114. Key Suppliers of Raw Materials
Table 115. Artificial Heart and Ventricular Assist Devices Distributors List
Table 116. Artificial Heart and Ventricular Assist Devices Customers List
Table 117. Artificial Heart and Ventricular Assist Devices Market Trends
Table 118. Artificial Heart and Ventricular Assist Devices Growth Drivers
Table 119. Artificial Heart and Ventricular Assist Devices Market Restraints
Table 120. Global Artificial Heart and Ventricular Assist Devices Sales Forecast by Type (2022-2027) & (K Units)
Table 121. Global Artificial Heart and Ventricular Assist Devices Sales Market Share Forecast by Type (2022-2027)
Table 122. Global Artificial Heart and Ventricular Assist Devices Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 123. Global Artificial Heart and Ventricular Assist Devices Revenue Market Share Forecast by Type (2022-2027)
Table 124. Global Artificial Heart and Ventricular Assist Devices Sales Forecast by Application (2022-2027) & (K Units)
Table 125. Global Artificial Heart and Ventricular Assist Devices Sales Market Share Forecast by Application (2022-2027)
Table 126. Global Artificial Heart and Ventricular Assist Devices Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 127. Global Artificial Heart and Ventricular Assist Devices Revenue Market Share Forecast by Application (2022-2027)
Table 128. Global Artificial Heart and Ventricular Assist Devices Sales Forecast by Region (2022-2027) & (K Units)
Table 129. Global Artificial Heart and Ventricular Assist Devices Sales Market Share Forecast by Region (2022-2027)
Table 130. Global Artificial Heart and Ventricular Assist Devices Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 131. Global Artificial Heart and Ventricular Assist Devices Revenue Market Share Forecast by Region (2022-2027)
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Artificial Heart and Ventricular Assist Devices
Figure 2. Global Artificial Heart and Ventricular Assist Devices Market Share by Type in 2020 & 2027
Figure 3. Artificial Heart Product Picture
Figure 4. Ventricular Assist Devices Product Picture
Figure 5. Global Artificial Heart and Ventricular Assist Devices Market Share by Application in 2020 & 2027
Figure 6. Coronary Heart Disease
Figure 7. Cerebrovascular Disease
Figure 8. Peripheral Arterial Disease
Figure 9. Rheumatic Heart Disease
Figure 10. Congenital Heart Disease
Figure 11. Deep Vein Thrombosis
Figure 12. Other
Figure 13. Global Artificial Heart and Ventricular Assist Devices Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Artificial Heart and Ventricular Assist Devices Market Size 2016-2027 (US$ Million)
Figure 15. Global Artificial Heart and Ventricular Assist Devices Sales 2016-2027 (K Units)
Figure 16. Global Artificial Heart and Ventricular Assist Devices Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 17. Artificial Heart and Ventricular Assist Devices Sales Share by Manufacturers in 2020
Figure 18. Global Artificial Heart and Ventricular Assist Devices Revenue Share by Manufacturers in 2020
Figure 19. The Global 5 and 10 Largest Artificial Heart and Ventricular Assist Devices Players: Market Share by Revenue in 2020
Figure 20. Artificial Heart and Ventricular Assist Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 21. Global Artificial Heart and Ventricular Assist Devices Sales Market Share by Region (2016-2021)
Figure 22. Global Artificial Heart and Ventricular Assist Devices Sales Market Share by Region in 2020
Figure 23. Global Artificial Heart and Ventricular Assist Devices Revenue Market Share by Region (2016-2021)
Figure 24. Global Artificial Heart and Ventricular Assist Devices Revenue Market Share by Region in 2020
Figure 25. U.S. Artificial Heart and Ventricular Assist Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Canada Artificial Heart and Ventricular Assist Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Germany Artificial Heart and Ventricular Assist Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. France Artificial Heart and Ventricular Assist Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. U.K. Artificial Heart and Ventricular Assist Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Italy Artificial Heart and Ventricular Assist Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Russia Artificial Heart and Ventricular Assist Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. China Artificial Heart and Ventricular Assist Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Japan Artificial Heart and Ventricular Assist Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. South Korea Artificial Heart and Ventricular Assist Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. India Artificial Heart and Ventricular Assist Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Australia Artificial Heart and Ventricular Assist Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Taiwan Artificial Heart and Ventricular Assist Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Indonesia Artificial Heart and Ventricular Assist Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Thailand Artificial Heart and Ventricular Assist Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Malaysia Artificial Heart and Ventricular Assist Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Philippines Artificial Heart and Ventricular Assist Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Vietnam Artificial Heart and Ventricular Assist Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Mexico Artificial Heart and Ventricular Assist Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Brazil Artificial Heart and Ventricular Assist Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Argentina Artificial Heart and Ventricular Assist Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Turkey Artificial Heart and Ventricular Assist Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Saudi Arabia Artificial Heart and Ventricular Assist Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. UAE Artificial Heart and Ventricular Assist Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 49. Sales Market Share of Artificial Heart and Ventricular Assist Devices by Type (2016-2021)
Figure 50. Sales Market Share of Artificial Heart and Ventricular Assist Devices by Application (2016-2021)
Figure 51. Sales Market Share of Artificial Heart and Ventricular Assist Devices by Application in 2020
Figure 52. Revenue Share of Artificial Heart and Ventricular Assist Devices by Application (2016-2021)
Figure 53. Revenue Share of Artificial Heart and Ventricular Assist Devices by Application in 2020
Figure 54. Manufacturing Cost Structure of Artificial Heart and Ventricular Assist Devices
Figure 55. Manufacturing Process Analysis of Artificial Heart and Ventricular Assist Devices
Figure 56. Artificial Heart and Ventricular Assist Devices Industrial Chain Analysis
Figure 57. Channels of Distribution
Figure 58. Distributors Profiles
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed